[Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases. A controlled study].
D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications; D001424:Bacterial Infections / Q000188:drug therapy*; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013411:Sulfadiazine / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
D000658:Amoxicillin; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D013411:Sulfadiazine; D014295:Trimethoprim; C024873:sulfadiazine, trimethoprim drug combination; D000096926:Benzenesulfonamides
Trimethoprim-Sulfamethoxazol versus Amoxycillin in der Therapie akuter bakterieller Exazerbationen bei chronischen unspezifischen Atemwegerkrankungen. Eine kontrollierte Studie.